MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 07.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
67.1 M |
Marktkapitalisierung |
$ 3.67 B |
EBITDA (LTM) |
$ -115 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-3.71 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market |  Canada |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
ANI Pharmaceuticals
ANIP
|
$ 81.6 | -0.49 % | $ 1.58 B | Nasdaq Global Market,SPB | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Amgen
AMGN
|
$ 342.65 | -0.08 % | $ 184 B | Nasdaq Global Select Market,SPB | USA |
 |
Adagene
ADAG
|
$ 2.75 | -5.5 % | $ 155 M | Nasdaq Global Market | China |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Aytu BioScience
AYTU
|
$ 2.63 | 1.74 % | $ 16.5 M | Nasdaq Capital Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.17 | -2.76 % | $ 7.63 B | Nasdaq Capital Market |  Australia |
 |
PainReform Ltd.
PRFX
|
$ 0.68 | -4.45 % | $ 308 K | Nasdaq Capital Market |  Israel |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Biogen
BIIB
|
$ 178.24 | 1.2 % | $ 26 B | Nasdaq Global Select Market,SPB | USA |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Beam Therapeutics
BEAM
|
$ 27.94 | -4.61 % | $ 2.3 B | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Ascendis Pharma A/S
ASND
|
$ 225.36 | 0.63 % | $ 5 B | Nasdaq Global Select Market |  Danmark |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
BioNTech SE
BNTX
|
$ 114.18 | -2.22 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Burford Capital Limited
BUR
|
$ 9.67 | 0.16 % | $ 1.52 B | NYSE | Britain |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 70.74 | 2.34 % | $ 9.46 B | Nasdaq Global Select Market,SPB | USA |
 |
CASI Pharmaceuticals
CASI
|
$ 0.99 | -0.01 % | $ 135 M | Nasdaq Capital Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Catalyst Biosciences
CBIO
|
$ 9.63 | -5.08 % | $ 634 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 4.05 | -1.22 % | $ 8.81 B | NYSE American | Israel |
 |
Amneal Pharmaceuticals
AMRX
|
$ 13.65 | -3.3 % | $ 4.22 B | NYSE | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Cerus Corporation
CERS
|
$ 2.32 | -0.22 % | $ 428 M | Nasdaq Global Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |